{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:17:47Z","timestamp":1791940667722,"version":"4.3.4"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":343,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.vph.2021.106829","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T13:33:58Z","timestamp":1610458438000},"page":"106829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Endothelial cells and SARS-CoV-2: An intimate relationship"],"prefix":"10.1016","volume":"137","author":[{"given":"Lucas Cunha","family":"Barbosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaynan Lopes","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luanna Prudencio","family":"de Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciane Vieira de Oliveira","family":"Rosario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9ria Pereira","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2021.106829_bb0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13045-020-00883-5","article-title":"Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: a pan-cancer analysis","volume":"13","author":"Chai","year":"2020","journal-title":"J. Hematol. Oncol.J Hematol Oncol."},{"key":"10.1016\/j.vph.2021.106829_bb0010","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","article-title":"Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study","volume":"7","author":"Goshua","year":"2020","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.vph.2021.106829_bb0015","doi-asserted-by":"crossref","first-page":"108427","DOI":"10.1016\/j.clim.2020.108427","article-title":"COVID-19 pathophysiology: A review","volume":"215","author":"Yuki","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.vph.2021.106829_bb0020","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13046-019-1156-5","article-title":"ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa\/VEGFR2\/ERK pathway","volume":"38","author":"Zhang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.vph.2021.106829_bb0025","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.1128\/JVI.01542-10","article-title":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2","volume":"84","author":"Matsuyama","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.vph.2021.106829_bb0030","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1128\/JVI.02232-10","article-title":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response","volume":"85","author":"Glowacka","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.vph.2021.106829_bb0035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.vph.2021.106829_bb0040","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01815-18","article-title":"TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection","volume":"93","author":"Iwata-Yoshikawa","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.vph.2021.106829_bb0045","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1073\/pnas.2002589117","article-title":"Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells","volume":"117","author":"Matsuyama","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.vph.2021.106829_bb0050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.vph.2021.106829_bb0055","doi-asserted-by":"crossref","first-page":"13221","DOI":"10.1128\/JVI.02078-14","article-title":"Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells","volume":"88","author":"Milewska","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.vph.2021.106829_bb0060","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41594-019-0233-y","article-title":"Structural basis for human coronavirus attachment to sialic acid receptors","volume":"26","author":"Tortorici","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.vph.2021.106829_bb0065","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1073\/pnas.1809667116","article-title":"Human coronaviruses OC43 and HKU1 bind to 9- O -acetylated sialic acids via a conserved receptor-binding site in spike protein domain A","volume":"116","author":"Hulswit","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.vph.2021.106829_bb0070","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1086\/427811","article-title":"Function of HAb18G\/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus","volume":"191","author":"Chen","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vph.2021.106829_bb0075","article-title":"Is COVID-19 an endothelial disease? Clinical and basic evidence","author":"Sardu","year":"2020","journal-title":"Med. Pharmacol."},{"key":"10.1016\/j.vph.2021.106829_bb0080","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.vph.2021.106829_bb0085","doi-asserted-by":"crossref","first-page":"2001634","DOI":"10.1183\/13993003.01634-2020","article-title":"Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?","volume":"56","author":"Huertas","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.vph.2021.106829_bb0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11912-020-00934-7","article-title":"COVID-19 and cancer: a comprehensive review","volume":"22","author":"Gosain","year":"2020","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.vph.2021.106829_bb0095","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.vph.2021.106829_bb0100","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science."},{"key":"10.1016\/j.vph.2021.106829_bb0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41368-020-0074-x","article-title":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa","volume":"12","author":"Xu","year":"2020","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.vph.2021.106829_bb0110","doi-asserted-by":"crossref","first-page":"14614","DOI":"10.1128\/JVI.79.23.14614-14621.2005","article-title":"ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia","volume":"79","author":"Jia","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.vph.2021.106829_bb0115","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000507305","article-title":"Should COVID-19 concern nephrologists? Why and to what extent? The emerging impasse of angiotensin blockade","volume":"144","author":"Perico","year":"2020","journal-title":"Nephron."},{"key":"10.1016\/j.vph.2021.106829_bb0120","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2021.106829_bb0125","series-title":"Encephalopathy as the Sentinel Sign of a Cortical Stroke in a Patient Infected With Coronavirus Disease-19 (COVID-19), Cureus","author":"Deliwala","year":"2020"},{"key":"10.1016\/j.vph.2021.106829_bb0130","series-title":"The 2019 coronavirus (SARS-CoV-2) surface protein (Spike) S1 Receptor Binding Domain undergoes conformational change upon heparin binding","first-page":"9","author":"Mycroft-West","year":"2020"},{"key":"10.1016\/j.vph.2021.106829_bb0135","series-title":"SARS-CoV-2 spike S1 receptor binding domain undergoes conformational change upon interaction with low molecular weight heparins","first-page":"15","author":"Mycroft-West","year":"2020"},{"key":"10.1016\/j.vph.2021.106829_bb0140","article-title":"Synthetic heparan sulfate mimetic pixatimod (PG545) potently inhibits SARS-CoV-2 by disrupting the spike-ACE2 interaction","author":"Guimond","year":"2020","journal-title":"Microbiology"},{"key":"10.1016\/j.vph.2021.106829_bb0145","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1124\/molpharm.120.000098","article-title":"Heparin-binding peptides as novel therapies to stop SARS-CoV-2 cellular entry and infection","volume":"98","author":"Tavassoly","year":"2020","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.vph.2021.106829_bb0150","article-title":"Preferential recognition and antagonism of SARS-CoV-2 spike glycoprotein binding to 3- O -sulfated heparan sulfate","author":"Tiwari","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.vph.2021.106829_bb0155","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"The Lancet."},{"key":"10.1016\/j.vph.2021.106829_bb0160","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.vph.2021.106829_bb0165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fnana.2020.00037","article-title":"Neuromechanisms of SARS-CoV-2: A review","volume":"14","author":"DosSantos","year":"2020","journal-title":"Front. Neuroanat"},{"key":"10.1016\/j.vph.2021.106829_bb0170","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.abc1669","article-title":"SARS-CoV-2 productively infects human gut enterocytes","volume":"369","author":"Lamers","year":"2020","journal-title":"Science."},{"key":"10.1016\/j.vph.2021.106829_bb0175","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.vph.2021.106829_bb0180","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.vph.2021.106829_bb0185","article-title":"The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in human and mouse brain","author":"Chen","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.vph.2021.106829_bb0190","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1161\/CIRCRESAHA.113.301811","article-title":"Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension","volume":"113","author":"Xia","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2021.106829_bb0195","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/path.1560","article-title":"Organ distribution of severe acute respiratory syndrome(SARS) associated coronavirus(SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways","volume":"203","author":"Ding","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.vph.2021.106829_bb0200","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1084\/jem.20050828","article-title":"Multiple organ infection and the pathogenesis of SARS","volume":"202","author":"Gu","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vph.2021.106829_bb0205","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/infdis\/jiv499","article-title":"Middle east respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4","volume":"213","author":"Li","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vph.2021.106829_bb0210","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.118.310367","article-title":"Thrombotic regulation from the endothelial cell perspectives","volume":"38","author":"Wang","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2021.106829_bb0215","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2021.106829_bb0220","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nri2171","article-title":"Evolving functions of endothelial cells in inflammation","volume":"7","author":"Pober","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.vph.2021.106829_bb0225","doi-asserted-by":"crossref","DOI":"10.1177\/1753466620933508","article-title":"Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications","volume":"14","author":"Pelaia","year":"2020","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.vph.2021.106829_bb0230","doi-asserted-by":"crossref","first-page":"108448","DOI":"10.1016\/j.clim.2020.108448","article-title":"COVID-19: immunology and treatment options","volume":"215","author":"Felsenstein","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.vph.2021.106829_bb0235","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41565-020-0732-3","article-title":"Immune-mediated approaches against COVID-19","volume":"15","author":"Florindo","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.vph.2021.106829_bb0240","doi-asserted-by":"crossref","unstructured":"N. Vabret, G.J. Britton, C. Gruber, S. Hegde, J. Kim, M. Kuksin, R. Levantovsky, L. Malle, A. Moreira, M.D. Park, L. Pia, E. Risson, M. Saffern, B. Salom\u00e9, M. Esai Selvan, M.P. Spindler, J. Tan, V. van der Heide, J.K. Gregory, K. Alexandropoulos, N. Bhardwaj, B.D. Brown, B. Greenbaum, Z.H. G\u00fcm\u00fc\u015f, D. Homann, A. Horowitz, A.O. Kamphorst, M.A. Curotto de Lafaille, S. Mehandru, M. Merad, R.M. Samstein, M. Agrawal, M. Aleynick, M. Belabed, M. Brown, M. Casanova-Acebes, J. Catalan, M. Centa, A. Charap, A. Chan, S.T. Chen, J. Chung, C.C. Bozkus, E. Cody, F. Cossarini, E. Dalla, N. Fernandez, J. Grout, D.F. Ruan, P. Hamon, E. Humblin, D. Jha, J. Kodysh, A. Leader, M. Lin, K. Lindblad, D. Lozano-Ojalvo, G. Lubitz, A. Magen, Z. Mahmood, G. Martinez-Delgado, J. Mateus-Tique, E. Meritt, C. Moon, J. Noel, T. O\u2019Donnell, M. Ota, T. Plitt, V. Pothula, J. Redes, I. Reyes Torres, M. Roberto, A.R. Sanchez-Paulete, J. Shang, A.S. Schanoski, M. Suprun, M. Tran, N. Vaninov, C.M. Wilk, J. Aguirre-Ghiso, D. Bogunovic, J. Cho, J. Faith, E. Grasset, P. Heeger, E. Kenigsberg, F. Krammer, U. Laserson, Immunology of COVID-19: current state of the science, Immunity. 52 (2020) 910\u2013941. https:\/\/doi.org\/10.1016\/j.immuni.2020.05.002.","DOI":"10.1016\/j.immuni.2020.05.002"},{"key":"10.1016\/j.vph.2021.106829_bb0245","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1038\/s41467-020-17292-4","article-title":"Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia","volume":"11","author":"De Biasi","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.vph.2021.106829_bb0250","article-title":"Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation","author":"Gao","year":"2020","journal-title":"Infect. Dis. (except HIV\/AIDS)"},{"key":"10.1016\/j.vph.2021.106829_bb0255","series-title":"Cellular crosstalk between airway epithelial and endothelial cells regulates barrier functions during exposure to double-stranded RNA","first-page":"12","author":"Blume","year":"2017"},{"key":"10.1016\/j.vph.2021.106829_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/01902140903026582","article-title":"Interactions between endothelial cells and epithelial cells in a combined cell model of airway mucosa: effects on tight junction permeability","volume":"36","author":"Chowdhury","year":"2010","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.vph.2021.106829_bb0265","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2016.1228439","article-title":"Regulation of endothelial and epithelial barrier functions by peptide hormones of the adrenomedullin family","volume":"4","author":"Garc\u00eda-Ponce","year":"2016","journal-title":"Tissue Barriers."},{"key":"10.1016\/j.vph.2021.106829_bb0270","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/01.RES.0000255690.03436.ae","article-title":"Phenotypic heterogeneity of the endothelium: II. Representative vascular beds","volume":"100","author":"Aird","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2021.106829_bb0275","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/thoraxjnl-2015-207461","article-title":"The pulmonary endothelium in acute respiratory distress syndrome: insights and therapeutic opportunities","volume":"71","author":"Millar","year":"2016","journal-title":"Thorax."},{"key":"10.1016\/j.vph.2021.106829_bb0280","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.kint.2020.05.013","article-title":"The case of complement activation in COVID-19 multiorgan impact","volume":"98","author":"Noris","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.vph.2021.106829_bb0285","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3389\/fimmu.2020.01518","article-title":"Targeting the NLRP3 inflammasome in severe COVID-19","volume":"11","author":"Freeman","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.vph.2021.106829_bb0290","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1378\/chest.107.4.1062","article-title":"Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS","volume":"107","author":"Meduri","year":"1995","journal-title":"Chest."},{"key":"10.1016\/j.vph.2021.106829_bb0295","doi-asserted-by":"crossref","first-page":"109906","DOI":"10.1016\/j.mehy.2020.109906","article-title":"Novel therapeutic targets for SARS-CoV-2-induced acute lung injury: targeting a potential IL-1\u03b2\/neutrophil extracellular traps feedback loop","volume":"143","author":"Yaqinuddin","year":"2020","journal-title":"Med. Hypotheses."},{"key":"10.1016\/j.vph.2021.106829_bb0300","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome","volume":"136","author":"Middleton","year":"2020","journal-title":"Blood."},{"key":"10.1016\/j.vph.2021.106829_bb0305","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41577-020-0407-1","article-title":"Tissue damage from neutrophil-induced oxidative stress in COVID-19","volume":"20","author":"Laforge","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.vph.2021.106829_bb0310","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.7861\/clinmed.2020-0252","article-title":"Potential role of endothelial cell surface ectopic redox complexes in COVID-19 disease pathogenesis","volume":"20","author":"Panfoli","year":"2020","journal-title":"Clin. Med."},{"key":"10.1016\/j.vph.2021.106829_bb0315","doi-asserted-by":"crossref","DOI":"10.5935\/1676-2444.20200049","article-title":"COVID-19: clinical and laboratory manifestations in novel coronavirus infection","author":"Xavier","year":"2020","journal-title":"J. Bras. Patol. E Med. Lab."},{"key":"10.1016\/j.vph.2021.106829_bb0320","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/s41375-020-0887-9","article-title":"SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine \u201cstorm\u201d and risk factor for damage of hematopoietic stem cells","volume":"34","author":"Ratajczak","year":"2020","journal-title":"Leukemia."},{"key":"10.1016\/j.vph.2021.106829_bb0325","article-title":"SARS-CoV-2 entry receptor ACE2 is expressed on very small CD45\u2212 precursors of hematopoietic and endothelial cells and in response to virus spike protein activates the Nlrp3 inflammasome","author":"Ratajczak","year":"2020","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.vph.2021.106829_bb0330","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.thromres.2020.06.027","article-title":"Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review","volume":"194","author":"Fletcher-Sandersj\u00f6\u00f6","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.vph.2021.106829_bb0335","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1111\/jth.14981","article-title":"COVID-19: a collision of complement, coagulation and inflammatory pathways","volume":"18","author":"Chauhan","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.vph.2021.106829_bb0340","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00277-020-04138-8","article-title":"COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure","volume":"99","author":"Marchetti","year":"2020","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.vph.2021.106829_bb0345","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.chom.2020.05.009","article-title":"The innate immune system: fighting on the front lines or fanning the flames of COVID-19?","volume":"27","author":"McKechnie","year":"2020","journal-title":"Cell Host Microbe."},{"key":"10.1016\/j.vph.2021.106829_bb0350","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.3390\/ijms21145168","article-title":"Covid-19: The rollercoaster of fibrin(ogen), D-dimer, Von Willebrand factor, P-selectin and their interactions with endothelial cells, platelets and erythrocytes","volume":"21","author":"Grobler","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.vph.2021.106829_bb0355","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3389\/fphys.2020.00989","article-title":"The enigma of endothelium in COVID-19","volume":"11","author":"Kaur","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.vph.2021.106829_bb0360","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s13054-020-03062-7","article-title":"The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection","volume":"24","author":"Pons","year":"2020","journal-title":"Crit. Care."},{"key":"10.1016\/j.vph.2021.106829_bb0365","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41440-020-0455-8","article-title":"Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors\u2014lessons from available evidence and insights into COVID-19","volume":"43","author":"Kai","year":"2020","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.vph.2021.106829_bb0370","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with Coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.vph.2021.106829_bb0375","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.18632\/aging.103000","article-title":"Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis","volume":"12","author":"Wang","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.vph.2021.106829_bb0380","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41577-020-0343-0","article-title":"COVID-19: the vasculature unleashed","volume":"20","author":"Teuwen","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.vph.2021.106829_bb0385","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1007\/s12325-020-01399-7","article-title":"Dysfunctional coagulation in COVID-19: from cell to bedside","volume":"37","author":"Wang","year":"2020","journal-title":"Adv. Ther."},{"key":"10.1016\/j.vph.2021.106829_bb0390","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1016\/S2352-3026(20)30215-5","article-title":"Endothelial cells orchestrate COVID-19 coagulopathy","volume":"7","author":"O\u2019Sullivan","year":"2020","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.vph.2021.106829_bb0395","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1161\/STROKEAHA.120.030335","article-title":"SARS-CoV-2 and stroke in a New York healthcare system","volume":"51","author":"Yaghi","year":"2020","journal-title":"Stroke."},{"key":"10.1016\/j.vph.2021.106829_bb0400","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1161\/STROKEAHA.120.030365","article-title":"Clinical characteristics and outcomes of COVID-19 patients with a history of stroke in Wuhan, China","volume":"51","author":"Qin","year":"2020","journal-title":"Stroke."},{"key":"10.1016\/j.vph.2021.106829_bb0405","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1161\/CIRCULATIONAHA.120.047525","article-title":"ST-elevation myocardial infarction in patients with COVID-19: clinical and angiographic outcomes","volume":"141","author":"Stefanini","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2021.106829_bb0410","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2147\/PPA.S271481","article-title":"Implications of bed rest for patients with acute deep vein thrombosis: a qualitative study","volume":"14","author":"Gong","year":"2020","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.vph.2021.106829_bb0415","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00063198-200209000-00008","article-title":"Bed rest versus ambulation in the initial treatment of patients with proximal deep vein thrombosis","volume":"8","author":"Partsch","year":"2002","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.vph.2021.106829_bb0420","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1590\/1677-5449.009616","article-title":"Trombose venosa profunda e v\u00edrus chicungunha","volume":"16","author":"Marques","year":"2017","journal-title":"J. Vasc. Bras."},{"key":"10.1016\/j.vph.2021.106829_bb0425","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.vph.2021.106829_bb0430","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1093\/eurheartj\/ehaa399","article-title":"ST-elevation myocardial infarction and pulmonary embolism in a patient with COVID-19 acute respiratory distress syndrome","volume":"41","author":"Ueki","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2021.106829_bb0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2020.06.063","article-title":"Characteristics and outcomes in patients presenting with COVID-19 and ST-segment elevation myocardial infarction","volume":"131","author":"Hamadeh","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.vph.2021.106829_bb0440","article-title":"The human brain vasculature shows a distinct expression pattern of SARS- CoV-2 entry factors","author":"Ghobrial","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.vph.2021.106829_bb0445","article-title":"Immune response and blood\u2013brain barrier dysfunction during viral neuroinvasion","author":"Chen","year":"2020","journal-title":"Innate Immun."},{"key":"10.1016\/j.vph.2021.106829_bb0450","doi-asserted-by":"crossref","unstructured":"L.V. De Oliveira Rosario, B.G. Da Rosa, T.L. Goncalves, D.I.L. Matias, C. Freitas, V.P. Ferrer, Glioblastoma factors increase the migration of human brain endothelial cells in vitro by increasing MMP-9\/CXCR4 levels, Anticancer Res. 40 (2020) 2725\u20132737. 10.21873\/anticanres.14244.","DOI":"10.21873\/anticanres.14244"},{"key":"10.1016\/j.vph.2021.106829_bb0455","doi-asserted-by":"crossref","unstructured":"L. Pellegrini, A. Albecka, D.L. Mallery, M.J. Kellner, D. Paul, A.P. Carter, L.C. James, M.A. Lancaster, SARS-CoV-2 infects brain choroid plexus and disrupts the blood-CSF-barrier, 2020.08.20.259937. https:\/\/doi.org\/10.1101\/2020.08.20.259937.","DOI":"10.1101\/2020.08.20.259937"},{"key":"10.1016\/j.vph.2021.106829_bb0460","article-title":"Neurological complications associated with the blood-brain barrier damage induced by the inflammatory response during SARS-CoV-2 infection","author":"Alquisiras-Burgos","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.vph.2021.106829_bb0465","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.conb.2013.06.006","article-title":"\u2018Sealing off the CNS\u2019: cellular and molecular regulation of blood\u2013brain barriergenesis","volume":"23","author":"Siegenthaler","year":"2013","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.vph.2021.106829_bb0470","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev-cellbio-100617-062608","article-title":"Development and cell biology of the blood-brain barrier","volume":"35","author":"Langen","year":"2019","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.vph.2021.106829_bb0475","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/v12010014","article-title":"Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system?","volume":"12","author":"Desforges","year":"2019","journal-title":"Viruses."},{"key":"10.1016\/j.vph.2021.106829_bb0480","article-title":"Neurological complications associated with the blood-brain barrier damage induced by the inflammatory response during SARS-CoV-2 infection","author":"Alquisiras-Burgos","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.vph.2021.106829_bb0485","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1001\/jamaneurol.2020.2065","article-title":"Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review","volume":"77","author":"Zubair","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.vph.2021.106829_bb0490","article-title":"The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in vitro models of the human blood\u2013brain barrier","author":"Buzhdygan","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.vph.2021.106829_bb0495","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/jmv.25915","article-title":"Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)","volume":"92","author":"Paniz-Mondolfi","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.vph.2021.106829_bb0500","series-title":"The human brain vasculature shows a distinct expression pattern of SARS-CoV-2 entry factors","author":"Ghobrial","year":"2020"},{"key":"10.1016\/j.vph.2021.106829_bb0505","article-title":"Immune response and blood\u2013brain barrier dysfunction during viral neuroinvasion","author":"Chen","year":"2020","journal-title":"Innate Immun."},{"key":"10.1016\/j.vph.2021.106829_bb0510","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.celrep.2019.01.036","article-title":"Flavivirus NS1 triggers tissue-specific vascular endothelial dysfunction reflecting disease tropism","volume":"26","author":"Puerta-Guardo","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.vph.2021.106829_bb0515","doi-asserted-by":"crossref","first-page":"110015","DOI":"10.1016\/j.mehy.2020.110015","article-title":"Endothelial dysfunction in Coronavirus disease 2019 (COVID-19): gender and age influences","volume":"144","author":"Froldi","year":"2020","journal-title":"Med. Hypotheses."},{"key":"10.1016\/j.vph.2021.106829_bb0520","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1161\/STROKEAHA.120.030791","article-title":"Ischemic stroke epidemiology during the COVID-19 pandemic: navigating uncharted waters with changing tides","volume":"51","author":"Tsivgoulis","year":"2020","journal-title":"Stroke."},{"key":"10.1016\/j.vph.2021.106829_bb0525","series-title":"SARS-CoV-2 S protein binding hACE2: viral entry, pathogenesis, prognosis, and potential therapeutic targets","first-page":"43","author":"Al-Zaidan","year":"2020"},{"key":"10.1016\/j.vph.2021.106829_bb0530","doi-asserted-by":"crossref","first-page":"106680","DOI":"10.1016\/j.vph.2020.106680","article-title":"Angiotensin converting enzyme: a review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection","volume":"130","author":"Ghafouri-Fard","year":"2020","journal-title":"Vascul Pharmacol."},{"key":"10.1016\/j.vph.2021.106829_bb0535","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7150\/jca.49462","article-title":"Expression of the SAR2-Cov-2 receptor ACE2 reveals the susceptibility of COVID-19 in non-small cell lung cancer","volume":"11","author":"Zhang","year":"2020","journal-title":"J. Cancer."},{"key":"10.1016\/j.vph.2021.106829_bb0540","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1158\/2159-8290.CD-ND2020-006","article-title":"Pivot to battle COVID-19","volume":"10","author":"Cancer Labs","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.vph.2021.106829_bb0545","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.3389\/fimmu.2019.02178","article-title":"Tumors vs. chronic wounds: an immune cell\u2019s perspective","volume":"10","author":"Hua","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.vph.2021.106829_bb0550","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3389\/fphys.2020.00990","article-title":"The role of sinusoidal endothelial cells in the axis of inflammation and cancer within the liver","volume":"11","author":"Wilkinson","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.vph.2021.106829_bb0555","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s42003-020-1088-9","article-title":"Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer","volume":"3","author":"Chakravarty","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.vph.2021.106829_bb0560","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13045-020-00907-0","article-title":"Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis","volume":"13","author":"Meng","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.vph.2021.106829_bb0565","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/GO.20.00097","article-title":"COVID-19 and cancer: lessons from a pooled meta-analysis","author":"Desai","year":"2020","journal-title":"JCO Glob. Oncol."},{"key":"10.1016\/j.vph.2021.106829_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(20)30149-2","article-title":"Risk of COVID-19 for patients with cancer","volume":"21","author":"Wang","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.vph.2021.106829_bb0575","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41585-020-0345-5","article-title":"Advanced renal cell carcinoma and COVID-19 \u2014 a personal perspective","volume":"17","author":"Ged","year":"2020","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.vph.2021.106829_bb0580","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1158\/2159-8290.CD-20-0516","article-title":"Case fatality rate of cancer patients with COVID-19 in a New York Hospital System","volume":"10","author":"Mehta","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.vph.2021.106829_bb0585","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.2337\/dc20-0643","article-title":"Exploring diseases\/traits and blood proteins causally related to expression of ACE2, the putative receptor of SARS-CoV-2: a Mendelian randomization analysis highlights tentative relevance of diabetes-related traits","volume":"43","author":"Rao","year":"2020","journal-title":"Diabetes Care."},{"key":"10.1016\/j.vph.2021.106829_bb0590","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3390\/cancers12061581","article-title":"Cancer and SARS-CoV-2 infection: diagnostic and therapeutic challenges","volume":"12","author":"Allegra","year":"2020","journal-title":"Cancers."},{"key":"10.1016\/j.vph.2021.106829_bb0595","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-20-0422","article-title":"Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak","author":"Dai","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.vph.2021.106829_bb0600","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.annonc.2020.04.006","article-title":"Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City","volume":"31","author":"Miyashita","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.vph.2021.106829_bb0605","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(20)31187-9","article-title":"Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study","volume":"395","author":"Kuderer","year":"2020","journal-title":"The Lancet"},{"key":"10.1016\/j.vph.2021.106829_bb0610","doi-asserted-by":"crossref","first-page":"102068","DOI":"10.1016\/j.ctrv.2020.102068","article-title":"SARS-CoV-2 and cancer: are they really partners in crime?","volume":"89","author":"van Dam","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.vph.2021.106829_bb0615","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/jamaoncol.2020.0980","article-title":"SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China","volume":"6","author":"Yu","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.vph.2021.106829_bb0620","doi-asserted-by":"crossref","DOI":"10.1111\/cts.12862","article-title":"Effect of common medications on the expression of SARS-CoV-2 entry receptors in kidney tissue","author":"Saheb Sharif-Askari","year":"2020","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.vph.2021.106829_bb0625","first-page":"852","article-title":"Vascular complications of cancer chemotherapy","volume":"32","author":"Cameron","year":"2016","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.vph.2021.106829_bb0630","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/CIRCULATIONAHA.115.018347","article-title":"Vascular toxicities of cancer therapies","volume":"133","author":"Herrmann","year":"2016","journal-title":"Circulation."},{"key":"10.1016\/j.vph.2021.106829_bb0635","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/bjh.16727","article-title":"Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action","volume":"189","author":"Kollias","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.vph.2021.106829_bb0640","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/rth2.12357","article-title":"Fibrinolytic therapy for refractory COVID-19 acute respiratory distress syndrome: scientific rationale and review","volume":"4","author":"Barrett","year":"2020","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.vph.2021.106829_bb0645","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s40265-020-01367-z","article-title":"Pharmaco-immunomodulatory therapy in COVID-19","volume":"80","author":"Rizk","year":"2020","journal-title":"Drugs."},{"key":"10.1016\/j.vph.2021.106829_bb0650","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1042\/CS20200163","article-title":"Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?","volume":"134","author":"Batlle","year":"2020","journal-title":"Clin. Sci."},{"key":"10.1016\/j.vph.2021.106829_bb0655","series-title":"Heparin - Century Prog","first-page":"43","article-title":"The anticoagulant and antithrombotic mechanisms of heparin","author":"Gray","year":"2012"},{"key":"10.1016\/j.vph.2021.106829_bb0660","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1124\/pr.115.011247","article-title":"Pharmacology of heparin and related drugs","volume":"68","author":"Mulloy","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.vph.2021.106829_bb0665","doi-asserted-by":"crossref","first-page":"20150589","DOI":"10.1098\/rsif.2015.0589","article-title":"Heparan sulfate and heparin interactions with proteins","volume":"12","author":"Meneghetti","year":"2015","journal-title":"J. R. Soc. Interface."},{"key":"10.1016\/j.vph.2021.106829_bb0670","article-title":"Immunity, endothelial injury and complement-induced coagulopathy in COVID-19","author":"Perico","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.vph.2021.106829_bb0675","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.vph.2021.106829_bb0680","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1172\/JCI200113799","article-title":"Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry","volume":"108","author":"Shukla","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2021.106829_bb0685","article-title":"Heparin inhibits cellular invasion by SARS-CoV-2: structural dependence of the interaction of the surface protein (spike) S1 receptor binding domain with heparin","author":"Mycroft-West","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.vph.2021.106829_bb0690","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40635-015-0072-z","article-title":"Heparins attenuated histone-mediated cytotoxicity in vitro and improved the survival in a rat model of histone-induced organ dysfunction","volume":"3","author":"Iba","year":"2015","journal-title":"Intensive Care Med. Exp."},{"key":"10.1016\/j.vph.2021.106829_bb0695","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/TA.0000000000002387","article-title":"Unfractionated heparin attenuates histone-mediated cytotoxicity in vitro and prevents intestinal microcirculatory dysfunction in histone-infused rats","volume":"87","author":"Zhu","year":"2019","journal-title":"J. Trauma Acute Care Surg."},{"key":"10.1016\/j.vph.2021.106829_bb0700","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/jth.14872","article-title":"Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19","volume":"18","author":"Whyte","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.vph.2021.106829_bb0705","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1111\/jth.14828","article-title":"Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): a case series","volume":"18","author":"Wang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.vph.2021.106829_bb0710","doi-asserted-by":"crossref","first-page":"102568","DOI":"10.1016\/j.autrev.2020.102568","article-title":"Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy","volume":"19","author":"Toniati","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.vph.2021.106829_bb0715","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jaci.2020.04.029","article-title":"Type I IFN immunoprofiling in COVID-19 patients","volume":"146","author":"Trouillet-Assant","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.vph.2021.106829_bb0720","article-title":"Dexamethasone in hospitalized patients with Covid-19 \u2014 preliminary report","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2021.106829_bb0725","author":"National Library of Medicine (US)"},{"key":"10.1016\/j.vph.2021.106829_bb0730","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2146\/ajhp070449","article-title":"Tocilizumab: the first interleukin-6-receptor inhibitor","volume":"65","author":"Sebba","year":"2008","journal-title":"Am. J. Health. Syst. Pharm."},{"key":"10.1016\/j.vph.2021.106829_bb0735","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1080\/21645515.2017.1316909","article-title":"Tocilizumab (Actemra)","volume":"13","author":"Sheppard","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.vph.2021.106829_bb0740","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab treatment in COVID-19: a single center experience","volume":"92","author":"Luo","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.vph.2021.106829_bb0745","doi-asserted-by":"crossref","first-page":"100418","DOI":"10.1016\/j.eclinm.2020.100418","article-title":"Tocilizumab for treatment of patients with severe COVID\u201319: a retrospective cohort study","volume":"24","author":"Kewan","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.vph.2021.106829_bb0750","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.vph.2021.106829_bb0755","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.vph.2021.106829_bb0760","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.chom.2020.07.005","article-title":"Retrospective multicenter cohort study shows early interferon therapy is associated with favorable clinical responses in COVID-19 patients","volume":"28","author":"Wang","year":"2020","journal-title":"Cell Host Microbe."},{"key":"10.1016\/j.vph.2021.106829_bb0765","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.vph.2021.106829_bb0770","article-title":"The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells","author":"Hoffmann","year":"2020","journal-title":"Mol. Biol."},{"key":"10.1016\/j.vph.2021.106829_bb0775","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jmv.25992","article-title":"ACE2 activators for the treatment of COVID 19 patients","volume":"92","author":"Rodr\u00edguez-Puertas","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.vph.2021.106829_bb0780","article-title":"Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2","author":"Zhao","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vph.2021.106829_bb0785","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.vph.2021.106829_bb0790","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus\u2013induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.vph.2021.106829_bb0795","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00202","article-title":"Therapeutic potential and challenges of natural killer cells in treatment of solid tumors","volume":"6","author":"Gras Navarro","year":"2015","journal-title":"Front. Immunol."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153718912100001X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153718912100001X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:19:57Z","timestamp":1761527997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153718912100001X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":159,"alternative-id":["S153718912100001X"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2021.106829","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints202010.0214.v1","asserted-by":"object"}]},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endothelial cells and SARS-CoV-2: An intimate relationship","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2021.106829","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106829"}}